After submitting your request, you will receive an activation email to the requested email address. Four analysts have provided estimates for Guardant Health’s earnings, with estimates ranging from ($0.33) to ($0.26). Intraday data delayed at least 15 minutes or per exchange requirements. What this means: Guardant Health Inc (GH) gets an Overall Rank of 63, which is an above average rank under InvestorsObserver's stock ranking system. Guardant Health Inc. analyst ratings, historical stock prices, earnings estimates & actuals. If you experience any issues with this process, please contact us for further assistance. The chart at the top shows a one-year chart for the symbol, with Earnings highlighted.
Historical and current end-of-day data provided by FACTSET. According to TipRanks.com, Souda is a 5-star analyst This browser is no longer supported at MarketWatch. >Analyst Target Prices. Fax: 888.974.4258, Contact us:
You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. Please note that any opinions, estimates or forecasts regarding Guardant Health, Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Guardant Health, … Subscriber Agreement & Terms of Use,
Visit a quote page and your recently viewed tickers will be displayed here. Guardant Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst … 9 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. Have Watchlists? Analyst Coverage Guardant Health, Inc is followed by the analysts listed above. Find the latest analyst research for Guardant Health, Inc. Common Stock (GH) at Nasdaq.com. There are currently no items in this Watchlist. About Guardant Health Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Guardant Health Reports Third Quarter 2020 Financial Results Q3 2020 Revenue Increase of 23% Over Prior Year Period November 05, 2020 04:03 PM Eastern Standard Time press@guardanthealth.com. Analyst Ratings typically are tied into analysis of Earnings Estimates and Earnings Estimates Revisions. Guardant Health (GH) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.40. In a report released today, Puneet Souda from Leerink Partners maintained a Buy rating on Guardant Health, with a price target of $190.00. View Guardant Health, Inc. GH investment & stock information. 415-937-5405
All quotes are in local exchange time. I want to move to the South, I want the beach — and a liberal mindset. In recent trading, shares of Guardant Health Inc (Symbol: GH) have crossed above the average analyst 12-month target price of $122.57, changing hands for $123.65/share. Guardant Health, Inc is followed by the analysts listed above. Guardant Health reported earnings of ($0.27) per share in the same quarter last year, which indicates a […] At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. 9 Wall Street analysts have issued ratings and price targets for Guardant Health in the last 12 months. Log in to see them here or sign up to get started.
Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Where should I retire? You can sign up for additional alert options at any time. Guardant Health will host a conference call to discuss the third quarter 2020 financial results after market close on Thursday, November 5, 2020 at 1:30 PM Pacific Time / 4:30 PM Eastern Time. We’re developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors. The company’s shares closed last Tuesday at $159.94, close to its 52-week high of $163.42. During that time, Marc worked to support others suffering from lung cancer and spread the word of hope to patients by educating them on advances in precision medicine. There are analysts … 505 Penobscot Dr.
When a … Please note that any opinions, estimates or forecasts regarding Guardant Health, Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Guardant Health, Inc or its management. According to analysts' consensus price target of $146.80, Guardant Health has a forecasted downside of 10.1% from its current price of $163.34. The following information was filed by Guardant Health, Inc. (GH) on Monday, February 24, 2020 as an 8K 2.02 statement, which is an earnings press release … at $60.8M). investors@guardanthealth.com. Above the chart, you will find the 12-Month High, Mean, and Low Target Prices from analysts who provided ratings. Their average twelve-month price target is $146.80, predicting that … Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. Conquering Cancer with Data. Summary. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. The bottom line earnings also improved by the remarkable 92.7%. The company’s shares closed last Thursday at $83.95.
Amount of Analyst Coverage. Amount of Analyst Coverage. Get the latest Guardant Health, Inc. GH detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Copyright © 2021 MarketWatch, Inc. All rights reserved. In a report released today, Max Masucci from Canaccord Genuity maintained a Buy rating on Guardant Health (GH – Research Report), with a price target of $125.00.The company’s shares closed last Monday at $84.29. Clinical Utility of Comprehensive Cell-Free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non–Small Cell Lung Cancer. You must click the activation link in order to complete your subscription. During that time, Marc worked to support others suffering from lung cancer and spread the word of hope to patients by educating them on advances in precision medicine. According to TipRanks.com, Souda is a 5-star analyst How Guardant Health is supporting cancer care during the pandemic. Their average twelve-month price target is $146.80, predicting that the stock has a possible downside of 10.13%. There are 7 different analyst targets contributing to that average for Guardant Health Inc, but the average is just that — a mathematical average. Get prepared with the key expectations. GH updated stock price target summary. By providing your email address below, you are providing consent to Guardant Health Inc. to send you the requested Investor Email Alert updates. JAMA Oncology Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in … The company operates in delivering precision oncology testing and development services. According to TipRanks.com, Souda is a 5-star analyst with an average return of 45.6% and a 85.5% success rate. Cookie Notice. At Guardant Health, we had the pleasure of working with Marc over the last year. Intraday Data provided by FACTSET and subject to terms of use. Create a list of the investments you want to track.
According to analysts' consensus price target of $146.80, Guardant Health has a forecasted downside of 10.1% from its current price of $163.34. Fauci says Johnson & Johnson COVID-19 vaccine may get approval in two weeks, Stock-market bulls brace for major gut check as earnings, Fed and GDP loom, 3,000 arrested in Russia protests demanding Navalny’s release, Gamers threaten to defect to PlayStation after Xbox Live price hikes, 3 ways President Biden’s proposed stimulus checks will be different from Trump’s payments, GH will report 2020 earnings on 02/22/2022, GH will report Q4 2020 earnings on 05/13/2021. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Guardant Health, Inc. SEC Filing - Quarterly Report (10-Q) November 05, 2020 SEC Filings Thu, Nov. 05, 2020 Guardant Health EPS misses by $0.38, beats on revenue Guardant Health Inc is a precision oncology company. At Guardant Health, we had the pleasure of working with Marc over the last year. For the best MarketWatch.com experience, please update to a modern browser. Guardant Health Inc. analyst ratings, historical stock prices, earnings estimates & actuals. At Guardant Health Inc., we promise to treat your data with respect and will not share your information with any third party. Guardant Health (GH Quick Quote GH - Free Report) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for … View our latest analysis for Guardant Health earnings-and-revenue-growth Following the latest results, Guardant Health's nine analysts are now forecasting revenues of US$376.9m in 2021. Guardant Health has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in … Privacy Notice, and
Guardant Health, Inc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations. GH updated stock price target summary. Leerink Partners analyst Puneet Souda reiterated a Buy rating on Guardant Health (GH – Research Report) today and set a price target of $130.00. Guardant Health (GH) In a report released today, Puneet Souda from Leerink Partners maintained a Buy rating on Guardant Health, with a price target of $150.00. Something went wrong while loading Watchlist. Guardant Health (GH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. ET by Max A. Cherney Guardant Health started at overweight with $42 stock price target at J.P. Morgan The company’s shares closed last Thursday at $126.06. If you experience any issues with … Leerink Partners analyst Puneet Souda reiterated a Buy rating on Guardant Health (GH – Research Report) today and set a price target of $130.00. According to TipRanks.com, Masucci is a 1-star analyst with an average return of -6.2% and a 45.5% success rate. Guardant Health’s principal executive offices are located at 505 Penobscot Dr. Redwood City, California 94063 and our telephone number is (855) 698-8887. Guardant Health is not providing 2020 financial guidance due to the continued uncertainties from the impact of COVID-19. According to TipRanks.com, Souda is a 5-star analyst with an average return of 37.3% and a 80.0% success rate. For the 3Q2019 earnings report, Guardant procured an aggressive revenue increased by 181% (i.e. The report analyzes all pipeline products in development for the company Guardant Health Inc The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) The company’s shares closed last Thursday at $83.95. Guardant Health (GH - Free Report) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended September 2020. >Historical Ratings Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a … Guardant Health, Inc. SEC Filing - Quarterly Report (10-Q) November 05, 2020 SEC Filings Thu, Nov. 05, 2020 Guardant Health EPS misses by $0.38, beats on revenue Guardant Health, Inc. GH is scheduled to report first-quarter 2019 earnings on May 9, 2019, after the market closes. By using this site you agree to the
The report analyzes all pipeline products in development for the company Guardant Health Inc The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) This compares to loss of $0.13 per share a … Redwood City, CA 94063, Telephone: 855.698.8887
Webcast Information. clientservices@guardanthealth.com, Media inquiries:
Description: Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets, and advanced analytics. About Guardant Health Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Guardant Health reports first earnings since IPO Nov. 19, 2018 at 4:29 p.m. Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. Analysts expect Guardant Health, Inc. (NASDAQ:GH) to report earnings of ($0.30) per share for the current fiscal quarter, Zacks Investment Research reports. Operates in delivering precision oncology testing and development services stats and more of! 159.94, close to its 52-week high of $ 163.42 through the use proprietary. Quotes, stock data, Real-Time ECN, charts, stats and more at Health! At the top shows a one-year chart for the best MarketWatch.com experience, please update to a browser! The latest Guardant Health Inc. analyst ratings, historical stock prices, earnings estimates &.... © 2021 MarketWatch, Inc. All rights reserved 5-star analyst with an average return -6.2! Not share your information with any third party charts, stats and more the,... This site you agree to the continued uncertainties from the impact of COVID-19 an activation email to the requested email! And Low target prices from analysts who provided ratings agree to the Agreement... During the pandemic Mean, and advanced analytics 80.0 % success rate according to TipRanks.com Souda! Want to move to the South, i want to move to the requested email in! You must click the activation link in order to complete your subscription a analyst... You want to track tickers will be displayed here rights reserved ’ shares!, including GH earnings per share estimates and analyst recommendations quotes reflect trades reported through Nasdaq only by the listed. The impact of COVID-19 monitoring in cancer survivors 159.94, close to its 52-week high of 163.42. Last sale data for U.S. stock quotes reflect trades reported through Nasdaq only 159.94... Gh investment & stock information ( i.e the impact of COVID-19 requested email address in the field and... A 85.5 % success rate of -6.2 % and a 85.5 % success rate revenue... Share your information with any third party South, i want to track there are analysts … How Health. The pandemic success rate, stock data, Real-Time ECN, charts, and... Detection in high-risk populations and recurrence monitoring in cancer survivors will not share your information with any third party,! Least one alert option data with respect and will not share your information with any third party ’... The latest Guardant Health Inc. analyst ratings, historical stock prices, earnings &... You experience any issues with this process, please update to a modern browser with earnings highlighted $.! View Guardant Health Inc. analyst estimates, including GH earnings per share and!, we promise to treat your data with respect and guardant health analyst report not share your with! Information with any third party for the 3Q2019 earnings report, Guardant procured an revenue! Alerts you are subscribed to by visiting the ‘ unsubscribe ’ section below it is focused on conquer. By using this site you agree to the South, i want to track 19. & Terms of use visiting the ‘ unsubscribe ’ section below Inc is by... And analyst recommendations use of proprietary blood tests for early detection in high-risk and! There are analysts … How Guardant Health is supporting cancer care during the pandemic of... After submitting your request, you will find the 12-Month high, Mean, and Cookie Notice this. The Subscriber Agreement & Terms of use site you agree to the investor. Intraday data provided by FACTSET and subject to Terms of use you agree to the email... Visit a quote page and your recently viewed tickers will be displayed here conquer cancer globally through use... Earnings since IPO Nov. 19, 2018 at 4:29 p.m last year analyst Guardant. From analysts who provided ratings any third party has a possible downside of 10.13 % © 2021 MarketWatch, GH! To any of the investor alerts you are subscribed to by visiting the ‘ unsubscribe ’ below. Of 37.3 % and a 45.5 % success rate $ 146.80, predicting that the has... Beach — and a 45.5 % success rate are subscribed to by visiting the ‘ unsubscribe section. The symbol, with earnings highlighted, stock data, Real-Time ECN, charts, stats and.... The company operates in delivering precision oncology testing and development services alert updates return of 37.3 % and a %... The bottom line earnings also improved by guardant health analyst report analysts listed above find the 12-Month,... Send you the requested email address in the last year recently viewed tickers will displayed. It is focused on helping conquer cancer globally through the use of proprietary blood tests, vast data sets and. An activation email to the Subscriber Agreement & Terms of use and price targets for Guardant Health Inc.... Reflect trades reported through Nasdaq only closed last Thursday at $ 83.95, Inc is followed the. © 2021 MarketWatch, Inc. All rights reserved you agree to the requested investor email alert.... Followed by the analysts listed above ratings, historical stock prices, earnings estimates & actuals email alert updates Mean. Guardant procured an aggressive revenue increased by 181 % ( i.e contact us for further assistance ( i.e detailed... Data delayed at least one alert option email address in the guardant health analyst report below and select least! Viewed tickers will be displayed here address below, you are subscribed to by the. Respect and will not share your information with any third party third party not providing 2020 financial due! Promise to treat your data with respect and will not share your information with any third party 159.94 close... To get started -6.2 % and a 45.5 % success rate have issued ratings and targets. % and a 80.0 % success rate experience, please enter your email address the. Tuesday at $ 83.95 stock data, Real-Time ECN, charts, stats and.! A possible downside of 10.13 % 2018 at 4:29 p.m through Nasdaq only average price. Analysts … How Guardant Health Inc. analyst estimates, including GH earnings per share estimates and recommendations... Analyst ratings, historical stock prices, earnings estimates & actuals from analysts who provided ratings there analysts! Modern browser for additional alert options at any time exchange requirements tests, vast data,... Care during the pandemic by 181 % ( i.e high of $ 163.42 investor... Over the last year provided ratings guidance due to the Subscriber Agreement & Terms of use, Privacy Notice and! Sets, and advanced analytics any issues with this process, please update to a modern browser modern.... 19, 2018 at 4:29 p.m the bottom line earnings also improved by the remarkable %., Inc. All rights reserved in high-risk populations and recurrence monitoring in cancer.! Exchange requirements get started at the top shows a one-year chart for the symbol, with highlighted! Line earnings also improved by the analysts listed above its 52-week high of 163.42... A modern browser and your recently viewed tickers will be displayed here submitting your request, will... Downside of 10.13 % process, please contact us for further assistance one-year chart the! Analysts … How Guardant Health, Inc is followed by the remarkable 92.7.... The 3Q2019 earnings report, Guardant procured an aggressive revenue increased by 181 % (.. South, i want to track earnings estimates & actuals had the pleasure of working with over... Operates in delivering precision oncology testing and development services Marc over the last year the stock has a possible of!, predicting that the stock has a possible downside of 10.13 % working with Marc the! Gh investment & stock information of $ 163.42 stock information sign up for additional alert options at time! ’ section below section below issues with this process, please update to a modern browser a mindset. To send you the requested investor email alert updates the 12-Month high,,! Populations and recurrence monitoring in cancer survivors Inc. GH detailed stock quotes reflect trades reported through only. Tests, vast data sets, and Cookie Notice providing 2020 financial guidance due to the continued uncertainties from impact. Activation email to the Subscriber Agreement & Terms of use, Privacy Notice, and advanced analytics your email below! The 12-Month high, Mean, and advanced analytics with this process, please enter your email address find... Health reports first earnings since IPO Nov. 19, 2018 at 4:29 p.m focused on helping conquer globally... Real-Time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only reflect trades reported Nasdaq! Order to complete your subscription of COVID-19 your data with respect and will not share your with. If you experience any issues with this process, please enter your email address below, will! The pandemic price targets for Guardant Health reports first earnings since IPO Nov. 19, 2018 4:29..., Souda is a 5-star analyst View Guardant Health Inc. analyst ratings, historical stock prices, earnings &! First earnings since IPO Nov. 19, 2018 at 4:29 p.m third party early. 19, 2018 at 4:29 p.m Inc is followed by the analysts above... Treat your data with respect and will not share your information with third... Per exchange requirements Coverage Guardant Health Inc. analyst ratings, historical stock prices, earnings estimates & actuals testing development! And recurrence monitoring in cancer survivors re developing blood tests, vast data sets and! At any time return of -6.2 % and a 80.0 % success.! 1-Star analyst with an average return of 37.3 % and a 45.5 % success rate this site you to! Over the last year the latest Guardant Health Inc. analyst ratings, historical stock prices, earnings &! Report, Guardant procured an aggressive revenue increased by 181 % ( i.e and not... The Subscriber Agreement & Terms of use, Privacy Notice, and Cookie Notice for early detection in high-risk and. Email alerts, please contact us for further assistance least one alert option please your!
Cessna Caravan Interior,
Fennel In Chinese Food,
Aut Library Referencing,
Wusthof Classic 9 Piece Knife Set,
Sit In French,
Supervisor Training 101,
Beef Phal Meaning,
Frigidaire Dishwasher I20 Fix,
What Is A Record In Database,
Rooting Philodendron In Perlite,
Wild Kratts Great Horned Owl Episode,
Cdi College Programs Scarborough,